FDA adds warning to baricitinib label: hypersensitivity

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1814卷 / 1期

关键词：

D O I：

10.1007/s40278-020-80990-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[11] FDA adds sweetener uses
不详
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1998, 98 (10) : 1112 - 1112
[12] FDA adds assessment tool
不详
FOOD TECHNOLOGY, 2008, 62 (02) : 14 - 14
[13] An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
Chaloupka, Frank J.
Warner, Kenneth E.
Acemoglu, Daron
Gruber, Jonathan
Laux, Fritz
Max, Wendy
Newhouse, Joseph
Schelling, Thomas
Sindelar, Jody
TOBACCO CONTROL, 2015, 24 (02) : 112 - 119
[14] Children's Exposure to Testosterone Gel Spurs FDA to Order Boxed Label Warning
Voelker, Rebecca
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (23): : 2428 - 2428
[15] FDA VARICELLA WARNING
TINKELMAN, DG
PEDIATRICS, 1992, 90 (03) : 479 - 480
[16] FDA rosiglitazone warning
Kuehn, Bridget M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (24): : 2858 - 2858
[17] FDA Warning for Etravirine
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (11) : 1050 - 1050
[18] FDA Azithromycin Warning
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1413): : 28 - 28
[19] FDA抗风湿药物Baricitinib上市
中国合理用药探索, 2018, (07) : 8 - 8
[20] FDA approves Eli Lilly's baricitinib
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (07) : 460 - 460

← 1 2 3 4 5 →